A detailed history of Td Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 3,694,780 shares of ABBV stock, worth $654 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
3,694,780
Previous 3,550,520 4.06%
Holding current value
$654 Million
Previous $609 Million 19.81%
% of portfolio
0.68%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $23.6 Million - $28.8 Million
144,260 Added 4.06%
3,694,780 $730 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $11.8 Million - $13.8 Million
76,500 Added 2.2%
3,550,520 $609 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $338 Million - $386 Million
2,116,997 Added 156.0%
3,474,020 $633 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $30.5 Million - $34.3 Million
221,463 Added 19.5%
1,357,023 $210 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $4.74 Million - $5.49 Million
35,481 Added 3.23%
1,135,560 $169 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $795,192 - $989,564
-6,001 Reduced 0.54%
1,100,079 $148 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $28.5 Million - $32.8 Million
197,090 Added 21.68%
1,106,080 $176 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $712,849 - $854,893
5,154 Added 0.57%
908,990 $147 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $4.07 Million - $4.67 Million
-30,330 Reduced 3.25%
903,836 $129 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $5.07 Million - $6.44 Million
-36,809 Reduced 3.79%
934,166 $143 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $5.35 Million - $6.64 Million
-40,548 Reduced 4.01%
970,975 $157 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $2.34 Million - $2.97 Million
-21,813 Reduced 2.11%
1,011,523 $137 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $2.04 Million - $2.31 Million
-19,140 Reduced 1.82%
1,033,336 $111 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $5.6 Million - $6.23 Million
-53,189 Reduced 4.81%
1,052,476 $122 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $4.16 Million - $4.58 Million
40,649 Added 3.82%
1,105,665 $120 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $4.28 Million - $5.77 Million
53,124 Added 5.25%
1,065,016 $114 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $11.8 Million - $13.8 Million
136,853 Added 15.64%
1,011,892 $88.6 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $1.91 Million - $2.56 Million
26,083 Added 3.07%
875,039 $85.9 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $5.71 Million - $8.66 Million
88,535 Added 11.64%
848,956 $64.7 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $3.48 Million - $4.35 Million
48,226 Added 6.77%
760,421 $67.3 Million
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $5.47 Million - $6.57 Million
86,817 Added 13.88%
712,195 $53.9 Million
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $455,366 - $582,065
6,931 Added 1.12%
625,378 $45.5 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $8.42 Million - $9.91 Million
-109,152 Reduced 15.0%
618,447 $49.8 Million
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $263,600 - $325,089
-3,386 Reduced 0.46%
727,599 $67.1 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $4.62 Million - $5.13 Million
-51,946 Reduced 6.63%
730,985 $69.1 Million
Q2 2018

Jul 31, 2018

SELL
$89.78 - $106.23 $70.6 Million - $83.6 Million
-786,899 Reduced 50.13%
782,931 $72.5 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $107 Million - $143 Million
-1,162,019 Reduced 42.54%
1,569,830 $149 Million
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $6.16 Million - $6.75 Million
-68,742 Reduced 2.45%
2,731,849 $264 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $196 Million - $250 Million
2,800,591
2,800,591 $249 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.